Deadline To Apply: December 22, 2017

Program Details:

The OBIO Capital Access Advisory Program operates downstream from existing entrepreneurship programs and targets the critical issue of access to capital at a post-seed stage of venture financing. OBIO CAAP strengthens Ontario’s cadre of investable human health technology companies, increasing high value deal flow.

BENEFITS FOR CAAP COMPANIES
  • OBIO advice & guidance on business goals and how to position for a successful raise
  • Investor targeting & introductions
  • Access to experts with business scaling know how
BENEFITS FOR INVESTORS
  • Access to peer-vetted high potential companies
  • High quality deal flow
  • Health science ecosystem intelligence
GOALS FOR FINANCIAL SUCCESS
  • A compelling & comprehensive investor package
  • Investor pitching excellence
  • A business plan approach that hits all the right notes
An information session for companies that want to apply to OBIO CAAP was held on November 22. Click here to view the presentation For additional information or questions, please contact Klaus Fiebig.

Eligibility Criteria:

  • Companies focused on developing health science products or services including but not limited to therapeutics, medical devices, diagnostics, or healthcare information technologies, and;
  • Enterprises that have already raised initial capital and are committed to raising a post-seed round of financing in the next 12 to 18 months.

Critical Dates:

The deadline for CAAP applications is Friday, December 22, 2017, 5:00PM EDT.

Organizer Name: OBIO
Contact Name: OBIO